Fenpropathrin
Based on 1 publication(s) in Google Scholar
Fenpropathrin is a synthetic pyrethroid insecticide in agriculture. Fenpropathrin may induces parkinsonian symptoms progressively.
Para uso exclusivo en investigación. No vendemos a pacientes.
- Pureza: 99.86%
- No. CAS: 39515-41-8
- Fòrmula: C22H23NO3
- Peso molecular:349.42
-
Almacenamiento:Pure form -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
-
Solvente y solubilidad
- Pureza y Documentación
- Referencias
-
Help & FAQs
-
Anti-Parkinson's Disease Compound Library
HY-L085
-
Neurodegenerative Disease-related Compound Library
HY-L086
-
Animal Disease Model Inducer Library
HY-L097
-
Human Metabolite Library
HY-L123
-
Bioactive Compound Library Max
HY-L181
-
MCE Bioactive Compound Library
HY-L001V
-
Bioactive Compound Library
HY-L001
-
Pesticide Compound Library
HY-L183
-
High-Throughput Bioactive Compound Library
HY-L205
-
Mass Spectrometry Human Metabolite Library
HY-L215
-
Environmental Pollutant Compound Library
HY-L247
Publications Citing Use of MedChemExpress (MCE) Fenpropathrin
More
Actividad biológica
Please do not refer to only one article to determine the experimental conditions. It is recommended to determine the optimal experimental conditions (animal strain, age, dosage, frequency and cycle, detection time and indicators, etc.) through preliminary experiments before the formal experiment.
Fenpropathrin can be used in animal modeling to create Parkinson's syndrome models. Fenpropathrin is lipophilic, allowing it to cross the blood-brain barrier, and it is characterized by rapid metabolic clearance in mammals[1].
Administration: 15 mg/kg, i.p. • 1 μL of 6 μg/μL Fenpropathrin solution, stereotaxical infusion • once daily for 60 days
(2) Half of the rats did not receive any treatment within 60 days after the last injection of Fenpropathrin, while the other half of the rats were euthanized 24 hours after the last Fenpropathrin treatment.
(3) For ST infusion, Fenpropathrin solution was injected into the right ventral tegmental area and substantia nigra pars compacta (SNc) at a flow rate of 0.2 μ L/min. After injection, the needle was left in place for 5 minutes to allow the drug to fully diffuse, and then the needle was slowly removed.
(4) Measure the levels of dopamine, DOPAC, and HVA in the striatum using HPLC.
(5) Slice the brain tissue into 15 μm thick sections using a low-temperature cryostat to analyze the immunoreactivity of DAT and VMAT2.
Behavioral observation: After 4 weeks of treatment, there was a decrease in movement activity, less climbing, reduced escape behavior, and slower movement.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 39515-41-8
-
Appearance <47°C Solid,>47°C Liquid
-
Peso molecular 349.42
-
Fòrmula C22H23NO3
-
Color White to off-white
-
SMILES
O=C(C1C(C)(C)C1(C)C)OC(C#N)C2=CC=CC(OC3=CC=CC=C3)=C2
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Pure form -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
Insect Sci
Fumarate mitigates disruption induced by fenpropathrin in the silkworm Bombyx mori (Lepidoptera): A metabolomics study. [Abstract]2023 Jun;30(3):789-802. PMID: 36097390
Solvente y solubilidad
DMSO : 100 mg/mL (286.19 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Pureza y Documentación
-
Ficha de datos (283 KB)
-
SDS (624 KB)
- English - EN (624 KB)
- Français - FR (624 KB)
- Deutsch - DE (624 KB)
- Norwegian - NO (624 KB)
- Español - ES (624 KB)
- Swedish - SV (624 KB)
- Italian - IT (624 KB)
- Korean - KR (624 KB)
- Portuguese - PT (624 KB)
-
Instrucciones de manejo (2659 KB)
Referencias
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.8619 mL | 14.3094 mL | 28.6189 mL | 71.5471 mL |
| 5 mM | 0.5724 mL | 2.8619 mL | 5.7238 mL | 14.3094 mL | |
| 10 mM | 0.2862 mL | 1.4309 mL | 2.8619 mL | 7.1547 mL | |
| 15 mM | 0.1908 mL | 0.9540 mL | 1.9079 mL | 4.7698 mL | |
| 20 mM | 0.1431 mL | 0.7155 mL | 1.4309 mL | 3.5774 mL | |
| 25 mM | 0.1145 mL | 0.5724 mL | 1.1448 mL | 2.8619 mL | |
| 30 mM | 0.0954 mL | 0.4770 mL | 0.9540 mL | 2.3849 mL | |
| 40 mM | 0.0715 mL | 0.3577 mL | 0.7155 mL | 1.7887 mL | |
| 50 mM | 0.0572 mL | 0.2862 mL | 0.5724 mL | 1.4309 mL | |
| 60 mM | 0.0477 mL | 0.2385 mL | 0.4770 mL | 1.1925 mL | |
| 80 mM | 0.0358 mL | 0.1789 mL | 0.3577 mL | 0.8943 mL | |
| 100 mM | 0.0286 mL | 0.1431 mL | 0.2862 mL | 0.7155 mL |
Fenpropathrin Related Classifications
HY-123178 Related Classifications
Powered by Bioz